Anthrax is an acute infectious disease
caused by the spore-forming bacterium Bacillus anthracis.
Anthrax most commonly occurs in wild and domestic lower vertebrates
(cattle, sheep, goats, camels, antelopes, and other herbivores),
but it can also occur in humans when they are exposed to infected
animals or tissue from infected animals.
Why has anthrax become a
current issue?
Because anthrax is considered to be a potential agent
for use in biological warfare, the Department of Defense (DoD) has
begun mandatory vaccination of all active duty military personnel
who might be involved in conflict.
How common is anthrax
and who can get it?
Anthrax is most common in agricultural regions where it occurs in
animals. These include South and Central America, Southern and Eastern
Europe, Asia, Africa, the Caribbean, and the Middle East. When anthrax
affects humans, it is usually due to an occupational exposure to
infected animals or their products. Workers who are exposed to dead
animals and animal products from other countries where anthrax is
more common may become infected with B. anthracis (industrial
anthrax). Anthrax in wild livestock has occurred in the United States.
How is anthrax transmitted?
Anthrax infection can occur in three forms: cutaneous (skin), inhalation,
and gastrointestinal. B. anthracis spores can live in the
soil for many years, and humans can become infected with anthrax
by handling products from infected animals or by inhaling anthrax
spores from contaminated animal products. Anthrax can also be spread
by eating undercooked meat from infected animals. It is rare to
find infected animals in the United States.
What are the symptoms
of anthrax?
Symptoms of disease vary depending on how the disease was contracted,
but symptoms usually occur within 7 days.
Cutaneous: Most
(about 95%) anthrax infections occur when the bacterium enters a
cut or abrasion on the skin, such as when handling contaminated
wool, hides, leather or hair products (especially goat hair) of
infected animals. Skin infection begins as a raised itchy bump that
resembles an insect bite but within 1-2 days develops into a vesicle
and then a painless ulcer, usually 1-3 cm in diameter, with a characteristic
black necrotic (dying) area in the center. Lymph glands in the adjacent
area may swell. About 20% of untreated cases of cutaneous anthrax
will result in death. Deaths are rare with appropriate antimicrobial
therapy.
Inhalation: Initial
symptoms may resemble a common cold. After several days, the symptoms
may progress to severe breathing problems and shock. Inhalation
anthrax is usually fatal.
Intestinal: The
intestinal disease form of anthrax may follow the consumption of
contaminated meat and is characterized by an acute inflammation
of the intestinal tract. Initial signs of nausea, loss of appetite,
vomiting, fever are followed by abdominal pain, vomiting of blood,
and severe diarrhea. Intestinal anthrax results in death in 25%
to 60% of cases.
Where is anthrax usually
found?
Anthrax can be found globally. It is more common in developing countries
or countries without veterinary public health programs. Certain
regions of the world (South and Central America, Southern and Eastern
Europe, Asia, Africa, the Caribbean, and the Middle East) report
more anthrax in animals than others.
Can anthrax be spread from person-to-person?
Direct person-to-person spread of anthrax is extremely unlikely
to occur. Communicability is not a concern in managing or visiting
with patients with inhalational anthrax.
Is there a way to prevent
infection?
In countries where anthrax is common and vaccination
levels of animal herds are low, humans should avoid contact with
livestock and animal products and avoid eating meat that has not
been properly slaughtered and cooked. Also, an anthrax vaccine has
been licensed for use in humans. The vaccine is reported to be 93%
effective in protecting against anthrax.
What is the anthrax vaccine?
The anthrax vaccine is manufactured and distributed
by BioPort, Corporation, Lansing, Michigan. The vaccine is a cell-free
filtrate vaccine, which means it contains no dead or live bacteria
in the preparation. The final product contains no more than 2.4
mg of aluminum hydroxide as adjuvant. Anthrax vaccines intended
for animals should not be used in humans.
Who should get vaccinated
against anthrax?
The Advisory Committee on Immunization Practices has
recommend anthrax vaccination for the following groups:
Persons who work directly with the organism in the
laboratory
Persons who work with imported animal hides or furs
in areas where standards are insufficient to prevent exposure to
anthrax spores.
Persons who handle potentially infected animal products
in high-incidence areas. (Incidence is low in the United States,
but veterinarians who travel to work in other countries where incidence
is higher should consider being vaccinated.)
Military personnel deployed to areas with high risk
for exposure to the organism (as when it is used as a biological
warfare weapon).
Pregnant women should be vaccinated only if absolutely
necessary.
What is the protocol for
anthrax vaccination?
The immunization consists of three subcutaneous injections
given 2 weeks apart followed by three additional subcutaneous injections
given at 6, 12, and 18 months. Annual booster injections of the
vaccine are recommended thereafter.
Are there adverse reactions
to the anthrax vaccine?
Mild local reactions occur in 30% of recipients and
consist of slight tenderness and redness at the injection site.
Severe local reactions are infrequent and consist of extensive swelling
of the forearm in addition to the local reaction. Systemic reactions
occur in fewer than 0.2% of recipients.
How is anthrax diagnosed?
Anthrax is diagnosed by isolating B. anthracis from the blood,
skin lesions, or respiratory secretions or by measuring specific
antibodies in the blood of persons with suspected cases.
Is there a treatment for anthrax?
Doctors can prescribe effective antibiotics. To be effective, treatment
should be initiated early. If left untreated, the disease can be
fatal.
|